Angelalign Technology (Angel) today announced that it will appeal the 10 Aug first-instance judgment by the Jinan Intermediate People’s Court in Jinan, China, which ordered Angel’s Chinese subsidiaries to stop using the masterForce biomechanics simulation system and ATreat digital diagnosis and design system to generate A7 and A7 Speed premolar extraction solutions.
The preliminary ruling applies only in China and has not yet taken effect. As a result, it has had no impact on the company’s customers or patients. The ruling would take effect if Angel’s appeal is unsuccessful.
Angel is confident that its A7 Premolar Extraction Solution does not infringe any valid patent. The company has prevailed in several patent disputes against the plaintiff in jurisdictions around the world and continues to advocate fair competition in the aligner and scanner market.
“The court’s decision is limited to China. Even in China, there is no immediate impact on our customers,” said Fox Hu, chief executive officer of Angelalign. “We are encouraged by the growing support from orthodontists for our professional solutions around the world. Given our success in a series of similar cases, we are confident in our appeal against our competitor.”
On 12 May 2026, the local division of the Unified Patent Court in Düsseldorf, Germany, issued a preliminary ruling rejecting the plaintiff’s request for an injunction requiring Angel to stop using the A7 Premolar Extraction Solution. The plaintiff did not appeal the ruling, which is now final. The European patent at issue and the Chinese patent involved in the Jinan case belong to the same patent family.
On 26 Jun 2026, the Zhengzhou Intermediate People’s Court in China issued two first-instance judgments in separate patent infringement disputes brought by the plaintiff against Angel, dismissing all of the plaintiff’s claims. The plaintiff has appealed both judgments.
Angel said it respects intellectual property rights and has a history of innovation spanning more than 20 years. The company said orthodontists worldwide, including some who work with competitors, recognise Angel as a leader in the treatment of complex orthodontic cases. It also noted that some competitors have adopted technologies inspired by its innovations, including its angelButton and A6 Mandibular Advancement System.
Angel has a market capitalisation of $2bn, strong profitability, a solid balance sheet and a global team of professionals. The company said these strengths position it as a long-term partner for orthodontists seeking to achieve clinical outcomes.


